The results demonstrated that MAP3K1 is one of the most closely associated genes with TRIB2 in glioma (Figure 2A,B), indicating that MAP3K1 might be functionally regulated by TRIB2 and could be used as a potential combined biomarker for glioma. This evidence concerns the gene MAP3K1 and central nervous system cancer.